Ultralife Corporation
ULBI
$7.44
$0.223.05%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 47.94M | 47.45M | 48.48M | 43.37M | 48.56M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 47.94M | 47.45M | 48.48M | 43.37M | 48.56M |
| Cost of Revenue | 34.08M | 37.34M | 36.43M | 33.75M | 36.96M |
| Gross Profit | 13.87M | 10.11M | 12.06M | 9.62M | 11.60M |
| SG&A Expenses | 6.32M | 6.52M | 6.47M | 7.12M | 6.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 43.62M | 46.81M | 45.72M | 43.73M | 45.98M |
| Operating Income | 4.32M | 632.00K | 2.76M | -357.00K | 2.58M |
| Income Before Tax | 2.99M | -663.00K | -10.21M | -1.75M | 1.11M |
| Income Tax Expenses | 468.00K | -192.00K | -2.75M | -504.00K | 243.00K |
| Earnings from Continuing Operations | 2.52M | -471.00K | -7.45M | -1.25M | 870.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 25.00K | 20.00K | 31.00K | 27.00K | 9.00K |
| Net Income | 2.54M | -451.00K | -7.42M | -1.22M | 879.00K |
| EBIT | 4.32M | 632.00K | 2.76M | -357.00K | 2.58M |
| EBITDA | 5.65M | 1.95M | 4.07M | 1.06M | 4.00M |
| EPS Basic | 0.15 | -0.03 | -0.45 | -0.07 | 0.05 |
| Normalized Basic EPS | 0.15 | 0.01 | 0.12 | -0.04 | 0.05 |
| EPS Diluted | 0.15 | -0.03 | -0.45 | -0.07 | 0.05 |
| Normalized Diluted EPS | 0.15 | 0.01 | 0.12 | -0.04 | 0.05 |
| Average Basic Shares Outstanding | 16.66M | 16.66M | 16.65M | 16.65M | 16.64M |
| Average Diluted Shares Outstanding | 16.71M | 16.66M | 16.65M | 16.65M | 16.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |